LENZ Therapeutics Cash Flow Statement (2022-2025) | LENZ

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M
Depreciation and Depletion (Quarter) 0.40M0.60M0.70M0.70M0.70M0.80M0.80M
Share-based Compensation (Quarter) 3.34M3.36M3.21M3.62M0.14M2.85M2.16M0.95M1.63M2.56M2.85M3.47M3.68M
Gains from Sales and Divestitures (Quarter) 0.40M0.45M0.50M0.55M0.60M0.65M0.70M
Gains from Investment Securities (Quarter) 0.04M0.14M0.85M0.01M1.05M-1.16M0.20M-0.20M
Asset Writedowns and Impairment (Quarter) 0.08M
Cash from Restructuring (Quarter) 4.82M-4.77M
Non-cash Items (Quarter) 0.79M608.95M0.77M0.79M1.21M1.47M0.69M
Cash from Operations (Quarter) -21.24M-22.09M-22.22M-22.43M-12.80M-23.94M-15.79M-10.58M-9.08M-16.05M-11.51M-8.59M-33.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.04M-0.04M0.56M1.12M0.28M0.96M1.36M1.42M1.13M0.89M0.78M0.61M
Depreciation & Amortization (CF) (Quarter) 0.44M0.58M0.65M0.68M0.00M0.80M0.80M0.01M0.02M0.01M0.03M0.04M0.02M0.12M0.11M
Change in Working Capital
Change in Inventory (Quarter) 3.33M
Change in Account Payables (Quarter) 0.58M0.30M0.39M-1.08M-0.57M-1.27M-2.69M-1.64M1.32M-0.77M-0.86M1.69M-0.16M
Change in Accured Expenses (Quarter) -1.67M1.16M1.17M0.45M-0.15M-7.23M-2.25M0.72M1.30M-1.20M2.69M4.46M5.03M
Investing Activities
Capital Expenditures (Quarter) 3.27M1.39M0.92M1.02M0.01M0.13M0.19M0.15M0.11M0.24M0.44M0.04M
Sales of Property, Plant and Equipment (Quarter) 0.89M
Change in Acquisitions & Divestments (Quarter) 90.00M80.25M18.00M13.00M22.00M34.90M52.09M58.12M52.41M43.34M
Cash from Investing Activities (Quarter) -170.67M-88.22M3.50M13.52M-0.01M18.00M-98.39M-62.23M-11.86M18.89M-0.41M-4.33M-89.81M
Financing Activities
Other financing activities (Quarter) -0.57M
Change in Capital Stock
Shares Issued (Quarter) -0.39M0.20M0.43M3.41M0.06M-3.90M0.04M26.10M0.65M
Preferred Shares Issued (Quarter) 66.00M16.98M-82.98M
Misc.
Cash from Financing Activities (Quarter) 0.41M-0.06M0.24M83.18M171.27M-2.14M29.82M0.05M0.04M26.49M0.60M122.61M
Change in Cash (Quarter) -191.91M-109.90M-18.78M-8.66M70.38M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M
Free Cash Flow (Quarter) -24.51M-23.48M-23.13M-23.45M-12.80M-23.94M-15.93M-10.77M-9.23M-16.16M-11.75M-9.03M-33.06M
Net Cash Flow (Quarter) -191.91M-109.90M-18.78M-8.66M70.38M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M